Global

African bonds outperforming EM bonds in 2021

  • Forex: Zambian Kwacha outperforming African peers on a quarter-to-date basis

  • Fixed Income: Outperformance of African bonds relative emerging market bonds likely to persist in the months ahead

  • Macroeconomic: Headline inflation in Nigeria slows in July, real interest rate remains deeply negative

https://cdn.tellimer.com/providers/badge-etm-analytics-q5QWdubobcjF5eDm1Ql3Y58rXgSDz4XDYWes4VjU.png
Kieran Siney @ ETM Analytics
https://cdn.tellimer.com/providers/badge-etm-analytics-q5QWdubobcjF5eDm1Ql3Y58rXgSDz4XDYWes4VjU.png
Takudzwa Ndawona @ ETM Analytics
August 18th, 2021
This is a premium report that requires access to ETM Analytics
ETM Analytics ETM Analytics
Driving meaningful change

Coverage

Africa

About

ETM Analytics provides financial market and economic intelligence using quantitative frameworks on emerging and frontier markets to traders, treasury professionals, buy-side and corporate executives.

Services

Market Intelligence
This team offers financial market and economic intelligence services to traders, treasury professionals, buy-side and corporate executives.
Consulting and Quantitative Solutions
Add-on
Internal resources include economists, coders, data specialists, econometric modelers, analysts and investment professionals. This leads to a diverse and experienced team, that can offer solutions at a level that is often superior in skill set to internal teams and at a better price point
Full list of services

Most Read

1 ∙ Strategy Note ∙ Global
Fixed income strategy: Top picks for 2024
2 ∙ Sovereign ∙ Ethiopia
Ethiopia: Debt suspension signals restructuring momentum; upgrade to Buy
3 ∙ Strategy Note ∙ Global
Geopolitics in EM: Conflicts everywhere but the biggest ones may freeze in 2024
4 ∙ Weekend Reading ∙ Global
The best and worst performing frontier market stocks so far this year
5 ∙ Strategy Note ∙ Saudi Arabia
OPEC+ could be more potent in 2024 as non-OPEC+ supply growth slows

Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument.

This publication is not intended for distribution to, or use by, any person or entity in any jurisdiction in any country where such distribution or use would be contrary to law or regulation, or which would subject Tellimer to any registration requirement within such jurisdiction or country.

This research is produced by a third party. The Tellimer team has had no editorial input into the content of the note.